ATG-010 and ATG-008
ATG-008&010-DLBCL-001
Phase 1 other terminated
Quick answer
ATG-010 and ATG-008 for Relapsed/Refractory Diffuse Large B-cell Lymphoma is a Phase 1 program (other) at Shanghai Antengene Corporation Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shanghai Antengene Corporation Limited
- Indication
- Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Phase
- Phase 1
- Modality
- other
- Status
- terminated